| Medical and Health Sciences | Lifetime | 352 | US 193 | 99.98 |
| Internal Medicine | Lifetime | 8 | US 2 | 99.75 |
| Epidemiology | Lifetime | 306 | US 159 | 99.62 |
| Cardiology and Cardiovascular Medicine | Lifetime | 237 | US 139 | 99.69 |
| Hematology | Lifetime | 175 | US 92 | 99.02 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 385 | US 213 | 98.84 |
| Nephrology | Lifetime | 543 | US 262 | 93.84 |
| Medical Genetics | Lifetime | 818 | US 403 | 89.87 |
| Epidemiology | 2021-2025 | 422 | US 141 | 96.30 |
| Internal Medicine | 2021-2025 | 32 | US 12 | 96.67 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 416 | US 189 | 94.81 |
| Nephrology | 2021-2025 | 301 | US 113 | 75.98 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 5 | US 2 | 99.95 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 6 | US 2 | 99.83 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 21 | US 13 | 99.84 |
| Cardiovascular Health and Risk Factors | Lifetime | 13 | US 10 | 99.69 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 106 | US 51 | 99.65 |
| Cardiovascular Disease and Adiposity | Lifetime | 79 | US 53 | 99.49 |
| Blood Pressure and Hypertension Studies | Lifetime | 133 | US 60 | 99.49 |
| Acute Ischemic Stroke Management | Lifetime | 150 | US 65 | 99.50 |
| Blood properties and coagulation | Lifetime | 65 | US 37 | 98.94 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 47 | US 25 | 98.94 |
| Lipoproteins and Cardiovascular Health | Lifetime | 133 | US 75 | 99.32 |
| Menopause: Health Impacts and Treatments | Lifetime | 44 | US 36 | 98.68 |
| Cardiovascular Health and Disease Prevention | Lifetime | 220 | US 104 | 98.79 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 398 | US 173 | 98.62 |
| Peripheral Artery Disease Management | Lifetime | 360 | US 217 | 97.75 |
| Chronic Kidney Disease and Diabetes | Lifetime | 298 | US 135 | 98.34 |
| Acute Myocardial Infarction Research | Lifetime | 575 | US 261 | 98.29 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 380 | US 163 | 97.41 |
| Cardiac Health and Mental Health | Lifetime | 452 | US 228 | 97.04 |
| Estrogen and related hormone effects | Lifetime | 914 | US 522 | 97.07 |
| Renal and Vascular Pathologies | Lifetime | 633 | US 330 | 96.52 |
| Sex and Gender in Healthcare | Lifetime | 62 | US 44 | 95.48 |
| Central Venous Catheters and Hemodialysis | Lifetime | 766 | US 346 | 95.39 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 671 | US 252 | 95.45 |
| Health, Environment, Cognitive Aging | Lifetime | 420 | US 208 | 94.61 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 602 | US 95 | 91.29 |
| Vitamin K Research Studies | Lifetime | 461 | US 197 | 89.29 |
| Case Reports on Hematomas | Lifetime | 302 | US 108 | 84.63 |
| Biomarkers in Disease Mechanisms | Lifetime | 745 | US 190 | 82.18 |
| GDF15 and Related Biomarkers | Lifetime | 971 | US 294 | 73.19 |
| Aortic Thrombus and Embolism | Lifetime | 624 | US 233 | 69.40 |
| Statistical Methods in Epidemiology | Lifetime | 180 | US 74 | 32.77 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 78 | US 32 | 98.94 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 86 | US 23 | 93.37 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 913 | US 225 | 94.01 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 239 | US 122 | 90.63 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 400 | US 79 | 85.56 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 710 | US 85 | 69.79 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 895 | US 195 | 55.44 |
